National Chicken Wing Day

Kate Walkenhorst

July 30, 2018

Yesterday was National Chicken Wing Day. Did you know that chicken wings originated in Buffalo, New York in 1964? Chicken wings have since become a popular appetizer for many occasions, from summer cookouts to game time get togethers. This hasn’t always been the case, however. Over the past century, the popularity of chicken has increased tremendously, and much of that can be attributed to the use of antibiotics to promote growth and prevent illness. Chickens are no longer pricey farm commodities only sought after for their eggs; they are now dominant within the meat industry.

What do chicken wings have to do with what we do here at Trilogy?

Over the past 10 years, there has been a huge push for “hormone-free” and “raised without antibiotics” meat and dairy products, including chicken. This push seems to stem from the antibiotic resistance that is found with current drugs being used today and how that translates to human health. Currently, the FDA only has a strategy in place to handle antimicrobial resistance in the industry. Analytical testing will take the forefront to police upcoming policies.

Last year, Trilogy did an “off the shelf” study to determine levels of certain veterinary drug residues found in several different meat and dairy samples, which included chicken wings, chicken nuggets, chicken strips, and other chicken products. See the results from this study, titled “Veterinary Drug Residues… Do the Label Claims Really Hold Up?”

Looking to find further information pertaining to chicken sampling and antibiotic testing? Here at Trilogy, we have over 40 antibiotics validated within our portfolio. We offer individual antibiotic testing as well as an analytical screen which includes all the compounds we offer. View the list of antibiotics we currently test for, or contact us to set up a customized antibiotic risk management plan.

About Trilogy

Trilogy is a food and feed safety laboratory specializing in mycotoxins, mycotoxin binder analysis, biogenic amines and animal drug residue testing. Trilogy Analytical Laboratory opened its doors in 1999 when its founders recognized a need in the mycotoxin industry for quick result turn-around utilizing reliable reference methods provided in an analytical setting. One of the main pillars of Trilogy’s strategy is to operate using a comprehensive quality program that we can rely on to ensure performance parameters are met every single time. From this philosophy the Trilogy line of quality products was born with the mycotoxin industry in mind.